{
  "target": "PFS_median_months",
  "target_ci": "PFS_median_CI",
  "target_ci_name": "CI",
  "feature_groups_to_use": ["patient_demographics", "disease_characteristics", "drug_class", "treatment_features"],
  "features": {
    "patient_demographics": [
      "gender_male_percent",
      "age_median",
      "no_smoker_percent",
      "ecog_1",
      "smoker_percent"
    ],
    "disease_characteristics": [
      "brain_metastase_yes",
      "disease_stage_recurrent", 
      "disease_stage_III", 
      "disease_stage_IV",
      "EGFR_wild", 
      "EGFR_positive_mutation"
    ],
    "drug_class": [
      "EGFR_TKI",
      "Platinum_Chemotherapy", 
      "Anti_VEGF", 
      "PD1_PDL1_Inhibitor",
      "Antimetabolite", 
      "Taxane", 
      "Antibody",
      "Placebo_Supportive-Care",
      "Chemotherapy", 
      "Targeted_Therapy",
      "Immunotherapy", 
      "Anti-angiogenic_Other"
    ],
    "treatment_features": [
      "combo_therapy",
      "treatment_complexity",
      "RCT_with_control_inter",
      "is_arm_control",
      "Population",
      "First-in-Class",
      "Next-Generation"
    ]
  },
  "interaction_terms": [
    {
      "name": "int_outcome_x_egfr",
      "feature1": "intervention_outcome",
      "feature2": "EGFR_TKI"
    },
    {
      "name": "int_outcome_x_immuno", 
      "feature1": "intervention_outcome",
      "feature2": "PD1_PDL1_Inhibitor"
    }
  ],
  "similarity_features": {
    "drug_class": [
      "EGFR_TKI",
      "Platinum_Chemotherapy", 
      "Anti_VEGF", 
      "PD1_PDL1_Inhibitor",
      "Antimetabolite", 
      "Taxane", 
      "Antibody",
      "Placebo_Supportive-Care"
    ]
  }
}
